XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 23,098 $ 21,775
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 17,274 15,623
Provision for credit losses 2,303 2,314
Stock-based compensation expense 4,521 6,155
Deferred income tax (benefit) expense (1,838) 87
Amortization of intangibles 1,012 982
Amortization of debt issuance costs 495 524
Amortization and accretion of debt 402 384
Net loss on divestitures, disposals and impairment charges 1,955 929
Net gain on property damage, net of insurance claims (417) (343)
Gain on sale of excess land 0 (658)
Changes in operating assets and liabilities that provided (used) cash:    
Accounts and preneed receivables (20,880) (4,607)
Inventories, prepaid and other current assets 1,543 (52)
Intangible and other non-current assets (3,624) (2,285)
Preneed funeral and cemetery trust investments (6,367) 990
Accounts payable 3,189 (117)
Accrued and other liabilities 5,909 5,297
Incentive payment from vendor 0 (6,000)
Deferred preneed funeral and cemetery revenue 7,546 11,110
Deferred preneed funeral and cemetery receipts held in trust 6,595 (2,259)
Net cash provided by operating activities 42,716 61,849
Cash flows from investing activities:    
Acquisitions of businesses 0 (44,000)
Proceeds from divestitures and sale of other assets 12,015 2,296
Proceeds from insurance claims 403 1,388
Capital expenditures (11,710) (13,069)
Net cash provided by (used in) investing activities 708 (53,385)
Cash flows from financing activities:    
Borrowings from the credit facility 32,100 68,100
Payments against the credit facility (71,200) (71,500)
Payment of debt issuance costs for the credit facility (782) 0
Payments on acquisition debt and obligations under finance leases (464) (491)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 2,181 1,207
Taxes paid on restricted stock vestings and exercise of stock options (424) (252)
Dividends paid on common stock (5,098) (5,023)
Net cash used in financing activities (43,687) (7,959)
Net (decrease) increase in cash and cash equivalents (263) 505
Cash and cash equivalents at beginning of period 1,523 1,170
Cash and cash equivalents at end of period $ 1,260 $ 1,675